Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a single-arm phase II clinical trial to evaluate the initial efficacy and safety of pembrolizumab combined with axitinib as neoadjuvant therapy for locally advanced non-metastatic clear cell renal cell carcinoma.
Epistemonikos ID: 096dd902c5c228d55bb36406a398bba641b04341
First added on: May 09, 2024